- This event has passed.
Workshop: Diving into drug repurposing
5th November at 10:30 am - 4:30 pm
Findacure, in partnership with MCDS Therapy, is delighted to announce its next training workshop, which will introduce patient groups to drug repurposing and guide them through assessing their own readiness for a drug repurposing project.
What will be covered?
- The basics – what is drug repurposing and why is it relevant to rare diseases?
- The main routes for delivering repurposed drugs to patients
- Identifying repurposing opportunities for your rare condition
- The roles of different interest groups in the repurposing process
- The input and impact of patient groups in drug repurposing
Frequently asked questions
Who can sign up?
This workshop is primarily for rare disease patient groups and will be most beneficial to those organisations who are looking to develop or deliver a drug repurposing project. The workshop will also provide a good introduction to any patient group interested in attending Findacure’s annual Drug Repurposing for Rare Diseases conference in February 2020.
Non-patient group attendees are welcome, however please note that these spaces are limited.
Will lunch be provided?
Yes – lunch and refreshments will be provided. If you have any special requirements, please note this in your registration form.
Do you cover expenses?
Findacure will reimburse travel expenses for rare disease patients, carers, patient groups and charities, up to the total value of £75.00 per person.
If your travel is likely to exceed this amount, please contact email@example.com ahead of the event so we can discuss whether further reimbursement will be possible.
All expenses, other than mileage, must be accompanied by valid receipts.
For further information on our expenses policy, please click here.
Findacure would like to thank The National Lottery Community Fund for providing funding for The Empowerment Programme.
Findacure would like to thank MCDS Therapy for providing funding for the ‘Diving into Drug Repurposing’ workshop.